GunturuK., Abu-KhalafM., and SaifM. “Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient With Pancreatic Cancer”. JOP. Journal of the Pancreas, Vol. 11, no. 5, Sept. 2010, pp. 484-5, doi:10.6092/1590-8577/3443.